ADAPTIVE BIOTECHNOLOGIES COR's ticker is ADPT and the CUSIP is 00650F109. A total of 113 filers reported holding ADAPTIVE BIOTECHNOLOGIES COR in Q2 2019. The put-call ratio across all filers is - and the average weighting 0.4%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q1 2022 | $5,084,000 | -54.9% | 366,290 | -8.8% | 0.00% | -50.0% |
| Q4 2021 | $11,266,000 | -26.0% | 401,505 | -10.4% | 0.01% | -33.3% |
| Q3 2021 | $15,229,000 | -20.0% | 448,035 | -3.8% | 0.01% | -25.0% |
| Q2 2021 | $19,029,000 | +684.7% | 465,729 | +673.0% | 0.02% | +700.0% |
| Q1 2021 | $2,425,000 | -90.0% | 60,247 | -85.4% | 0.00% | -91.7% |
| Q4 2020 | $24,370,000 | +63.5% | 412,134 | +34.4% | 0.02% | +41.2% |
| Q3 2020 | $14,908,000 | +25.4% | 306,565 | +24.8% | 0.02% | +21.4% |
| Q2 2020 | $11,887,000 | +1904.6% | 245,705 | +1050.4% | 0.01% | +1300.0% |
| Q1 2020 | $593,000 | -42.4% | 21,358 | -37.9% | 0.00% | 0.0% |
| Q4 2019 | $1,029,000 | -46.6% | 34,397 | -45.0% | 0.00% | -50.0% |
| Q3 2019 | $1,927,000 | -80.4% | 62,571 | -69.3% | 0.00% | -77.8% |
| Q2 2019 | $9,844,000 | – | 203,805 | – | 0.01% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Blue Water Life Science Advisors, LP | 3,030,434 | $20,334,212 | 13.72% |
| BERYLSON CAPITAL PARTNERS, LLC | 228,000 | $1,529,880 | 4.32% |
| Eagle Health Investments LP | 1,214,860 | $8,151,711 | 1.52% |
| Matrix Capital Management Company, LP | 11,572,590 | $77,652,079 | 0.90% |
| Triatomic Management LP | 121,166 | $813,024 | 0.83% |
| VIKING GLOBAL INVESTORS LP | 29,993,708 | $201,257,781 | 0.82% |
| Aristotle Atlantic Partners, LLC | 3,104,961 | $20,834,288 | 0.78% |
| Pier Capital, LLC | 737,589 | $4,949,222 | 0.71% |
| ARK Investment Management | 10,453,752 | $70,144,675 | 0.46% |
| Nikko Asset Management Americas, Inc. | 6,384,047 | $42,773,115 | 0.45% |